[EN] PYRROLE DERIVATIVES AS ALPHA 7 NACHR MODULATORS<br/>[FR] DÉRIVÉS DE PYRROLE UTILISÉS COMME MODULATEURS DES RÉCEPTEURS NICOTINIQUES À L'ACÉTYLCHOLINE (NACHR) ALPHA-7
申请人:LUPIN LTD
公开号:WO2014141091A1
公开(公告)日:2014-09-18
Disclosed are compounds of the Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the α7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.
本发明涉及化合物的公式(I),其中R1,R2,R3,R4,R5,R6,R7和m如本文所述,作为尼古丁酸乙酰胆碱受体的调节剂,特别是α7亚型,它们的互变异构体,立体异构体及其药学上可接受的盐,制药组合物以及与适当的其他药物的组合物。还公开了化合物的制备过程以及它们在治疗中的预期用途,特别是在预防和/或治疗阿尔茨海默病,轻度认知障碍和老年性痴呆等疾病中的应用。